• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Virol . Genome surveillance of SARS-CoV-2 Omicron XBB subvariants in Wuhan in June 2023

tetano

Editor, Senior Moderator
Arch Virol


. 2026 Jan 7;171(2):38.
doi: 10.1007/s00705-025-06453-9. Genome surveillance of SARS-CoV-2 Omicron XBB subvariants in Wuhan in June 2023

Yi Yan[SUP] #[/SUP][SUP] 1 [/SUP], Zhiyong Pan[SUP] #[/SUP][SUP] 1 [/SUP], Liangwei Mao[SUP] 2 [/SUP], Peihua Niu[SUP] 3 [/SUP], Fei Lu[SUP] 2 [/SUP], Yirong Li[SUP] 4 [/SUP], Zhiqiang Li[SUP] 5 [/SUP]



Affiliations
Abstract

The COVID-19 pandemic caused by SARS-CoV-2 has had a significant impact on global social and economic activities. The continuous emergence of new SARS-CoV-2 variants has made the global pandemic of COVID-19 difficult to predict. Therefore, it is of great significance to closely monitor the SARS-CoV-2 epidemic and understand the evolution and transmission characteristics of SARS-CoV-2. In this study, we examined 36 cases of SARS-CoV-2 infection in Wuhan in June 2023. Genomic surveillance revealed that this outbreak was caused by Omicron XBB variants, among which FY.3 and its descendants FY.3.1 and FY.3.2 dominated, and this trend was consistent with the prevalence of SARS-CoV-2 nationwide in June and July. Analysis of sequence variations within hosts and between populations suggested that the S and ORF8 genes had undergone positive selection, possibly due to their important role in host adaptation, suggesting that some of these variations might be harmful mutations that reduce vaccine effectiveness. These findings may provide insights that will aid in predicting the evolutionary direction of SARS-CoV-2 in terms of variant competition, informing the design of next-generation multivalent vaccines and therapeutic strategies targeting conserved or rapidly evolving regions such as the S and ORF8 genes and supporting the evaluation and adjustment of surveillance, prevention, and control strategies in the Wuhan region.


 
Back
Top Bottom